SCHEMBL7385753

SCHEMBL7385753

O=C(O)C1(c2ccc(Cl)cc2)CCCO1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 2/20 0.44
ITGA4 P13612 2/20 0.44
ITGB7 P26010 2/20 0.44
ALDH1A1 P00352 2/20 0.43
HDAC4 P56524 1/20 0.41
HSD11B1 P28845 7/20 0.41
CCR2 P41597 1/20 0.40
MAPK1 P28482 1/20 0.39
TET3 O43151 1/20 0.38
KMT2A Q03164 1/20 0.38
FBXL19 Q6PCT2 1/20 0.38
CXXC5 Q7LFL8 1/20 0.38
KDM2B Q8NHM5 1/20 0.38
CXXC4 Q9H2H0 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
LMNA P02545 1/20 0.36
MAP4K4 O95819 1/20 0.36
PHGDH O43175 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4829823 0.84 AKR1C1 (0.48) ITGB1ITGA4ITGB7ALDH1A1HDAC4
SCHEMBL7384751 0.83 ITGB1 (0.43) ITGB1ITGA4ITGB7ALDH1A1MAPK1
SCHEMBL7388625 0.83 ITGB1 (0.44) ITGB1ITGA4ITGB7HSD11B1KMT2A
SCHEMBL11021630 0.80 MAPK1 (0.47) ALDH1A1HDAC4HSD11B1CCR2MAPK1
SCHEMBL7379375 0.80 ITGB1 (0.46) ITGB1ITGA4ITGB7KMT2A
SCHEMBL7388060 0.80 ITGB1 (0.47) ITGB1ITGA4ITGB7ALDH1A1HSD11B1
SCHEMBL7378305 0.80 CYP3A4 (0.46) ITGB1ITGA4ITGB7ALDH1A1TET3
SCHEMBL10848298 0.79 AKR1C1 (0.52) ITGB1ITGA4ITGB7ALDH1A1HDAC4
SCHEMBL11121862 0.78 CCR2 (0.43) CCR2
SCHEMBL7386208 0.76 ITGB1 (0.49) ITGB1ITGA4ITGB7CCR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420418-B1 INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE MERCK & CO., INC. 2002-07-16 US disclosed
WO-2001012183-A1 HETEROCYCLE AMIDES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 2001-02-22 WO disclosed